WuXi AppTec announced the opening of its expanded Laboratory Testing Division (LTD) facility in New Jersey. The new facility will enhance WuXi's integrated testing service portfolio enabling drug developers to accelerate their projects from labs to patients.
The expansion will double total operation space to more than 115,000 square feet, and will create over 200 jobs. After the expansion, LTD's combined New Jersey operation will be one of the largest laboratories for preclinical and clinical drug development testing in the United States.
"As a renowned global company in life sciences industry, WuXi AppTec is an essential part of New Jersey's pharmaceutical community. The commitment shown by global companies such as WuXi demonstrates that New Jersey is a good place for science and technology companies to do business," said Glenn Johnson, Mayor of Cranbury, NJ.
The new site will establish a center of excellence for drug development and provide high quality services to the US pharmaceutical and biotech industries. Furthermore, WuXi will recruit extensively from the local talent base, further contributing to economic growth locally.
"The Garden State continues to be an important life science hub. This expansion will allow our team to deliver high quality service with faster turnaround times, better leverage the resources and expertise of the local pharmaceutical and biotechnology community, and develop a stronger connection with our customers," said Dr. Jason Liu, SVP of WuXi AppTec and Chief Operating Officer of the LTD.